The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents
- PMID: 20034613
- PMCID: PMC2922846
- DOI: 10.1016/j.biopsych.2009.10.018
The female urine sniffing test: a novel approach for assessing reward-seeking behavior in rodents
Abstract
Background: Abnormal hedonic behavior is a key feature of many psychiatric disorders. Several paradigms measure reward-seeking behavior in rodents, but each has limitations. We describe a novel approach for monitoring reward-seeking behavior in rodents: sniffing of estrus female urine by male mice, along with number of ultrasonic vocalizations (USVs) emitted during the test.
Methods: The female urine sniffing test (FUST) was designed to monitor reward-seeking activity in rodents together with tests of helplessness and sweet solution preference. USVs and dopamine release from the nucleus accumbens (NAc) were recorded. Sniffing activity was measured in 1) manipulation-naive C57BL/6J and 129S1/SVImJ mice and Wistar-Kyoto rats; 2) stressed mice; 3) two groups of mice that underwent the learned helplessness paradigm-one untreated, and one treated with the SSRI citalopram; and 4) GluR6 knockout mice, known to display lithium-responsive, mania-related behaviors.
Results: Males from all three strains spent significantly longer sniffing female urine than sniffing water. Males emitted USVs and showed significantly elevated NAc dopamine levels while sniffing urine. Foot-shock stress significantly reduced female urine sniffing time. Compared with mice that did not undergo the LH paradigm, LH males spent less time sniffing female urine, and citalopram treatment alleviated this reduction. Compared with their wildtype littermates, GluR6KO males sniffed female urine longer and showed enhanced saccharin preference.
Conclusions: In rodents, sniffing female urine is a preferred activity accompanied by biological changes previously linked to reward-seeking activities. The FUST is sensitive to behavioral and genetic manipulation and to relevant drug treatment.
Copyright 2010 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
The authors report no biomedical financial interests or potential conflicts of interest. Dr. Manji is now with Johnson and Johnson Pharmaceutical Research and Development (Titusville, NJ), and Dr. Maria Luisa Scattoni is now with the Instituto Superiore di Sanita (Rome, Italy). Ioline Henter provided invaluable editorial assistance.
Figures
References
-
- Barbano MF, Cador M. Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology. 2007;191:497–506. - PubMed
-
- Klein DF. Endogenomorphic depression. A conceptual and terminological revision. Arch Gen Psychiatry. 1974;31:447–454. - PubMed
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th. Washington, DC: American Psychiatric Association; 2000.
-
- Hasler G, Drevets WC, Gould TD, Gottesman MHK., II Toward constructing an endophenotype strategy for bipolar disorders. Biol Psychiatry. 2006;60:93–105. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
